These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 3395400
1. Tissue distribution of the novel antitussive compound vadocaine hydrochloride in white female mice studied by whole-body autoradiography. Vuorela A, Mäntylä R, Männistö PT. Arzneimittelforschung; 1988 Apr; 38(4A):628-30. PubMed ID: 3395400 [Abstract] [Full Text] [Related]
2. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals. Mäntylä R, Männistö PT, Vuorela A, Nissinen E. Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers. Karttunen P, Männistö PT, Tukiainen H, Uusitupa M, Nissinen E. Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402 [Abstract] [Full Text] [Related]
4. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride. Karttunen P, Männistö PT, Lahovaara S, Havas A. Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395 [Abstract] [Full Text] [Related]
5. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice. Etemadzadeh E, Ahtee L, Männistö PT. Arzneimittelforschung; 1988 Apr; 38(4A):620-3. PubMed ID: 3395398 [Abstract] [Full Text] [Related]
6. Steady state pharmacokinetics of the new antitussive compound vadocaine hydrochloride. Silvasti M, Karttunen P, Tukiainen H, Mykkänen M, Ottoila P. Arzneimittelforschung; 1990 Apr; 40(4):453-6. PubMed ID: 2357246 [Abstract] [Full Text] [Related]
7. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models. Männistö PT, Karttunen P, Lahovaara S, Nissinen E, Davies JE, Algate DR, Baines MW. Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394 [Abstract] [Full Text] [Related]
8. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers. Silvasti M, Karttunen P, Tukiainen H, Mykkänen M, Hänninen U, Välttilä S. Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390 [Abstract] [Full Text] [Related]
9. First human studies on the safety and antitussive activity of vadocaine hydrochloride. Karttunen P, Tukiainen H, Uusitupa M, Männistö PT. Arzneimittelforschung; 1988 Apr; 38(4A):631-4. PubMed ID: 3395401 [Abstract] [Full Text] [Related]
10. Assessment of the safety margin of vadocaine hydrochloride in man. Karttunen P, Uusitupa M, Helin M, Tukiainen H, Silvasti M. Arzneimittelforschung; 1988 Apr; 38(4A):642-6. PubMed ID: 3395404 [Abstract] [Full Text] [Related]
11. Assessment of the antitussive effect of vadocaine hydrochloride using citric acid-induced cough in healthy volunteers. Karttunen P. Arzneimittelforschung; 1988 Apr; 38(4A):639-41. PubMed ID: 3395403 [Abstract] [Full Text] [Related]
12. Cardiovascular and ventilator effects of vadocaine hydrochloride in urethane-anaesthetized rats and guinea-pigs. Paakkari I, Svartström-Fraser M. Arzneimittelforschung; 1988 Apr; 38(4A):617-9. PubMed ID: 3395397 [Abstract] [Full Text] [Related]
13. Comparison of the effects of two opioid antitussives, vadocaine hydrochloride, clobutinol and lidocaine on lung mechanics in guinea-pigs. Salonen RO. Arzneimittelforschung; 1988 Apr; 38(4A):609-12. PubMed ID: 3395396 [Abstract] [Full Text] [Related]
14. Distribution and elimination of RGH-5002 in rats. Terjéki E, Pátfalusi M, Trafikánt G, Kapás M. Acta Physiol Hung; 1995 Apr; 83(2):143-50. PubMed ID: 8588501 [Abstract] [Full Text] [Related]
15. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H. Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [Abstract] [Full Text] [Related]
17. Whole body distribution of the quaternary ammonium compound thiazinamium (N-methylpromethazine) and promethazine in monkey and mice. Jonkman JH, Westenberg HG, Rijntjes NV, van der Kleijn E, Lindeboom SF. Arzneimittelforschung; 1983 Apr; 33(2):223-8. PubMed ID: 6133524 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice. Ishii S, Mochizuki T, Nagao T, Kudo S, Fujita A, Taniguchi K, Kondo S, Kiyoki M. Arzneimittelforschung; 1995 May; 45(5):644-56. PubMed ID: 7612069 [Abstract] [Full Text] [Related]